2020
Overview
Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenia, is a bleeding disorder characterized by an abnormally low platelet count. Platelets are the blood cells responsible for clotting, so their shortage leads to easy bruising, small pinpoint skin hemorrhages called petechiae, prolonged bleeding from cuts, and, in severe cases, more serious internal bleeding. In ITP the immune system mistakenly produces antibodies against the body's own platelets, marking them for premature destruction, mainly in the spleen, while also impairing platelet production. The term idiopathic reflects that the trigger is often unknown, though the disorder can follow infections or arise alongside other immune conditions. ITP affects both children and adults, tends to be acute and self-limiting in children but more chronic in adults, and is generally more common in women. Diagnosis is based on the blood count and exclusion of other causes of low platelets, and treatment, when needed, aims to raise the platelet count using corticosteroids, immunoglobulins, other immune-modulating therapies, or removal of the spleen. Research relevant to this topic in Hematology and Oncology Research includes work on laboratory tests used in the diagnosis of immune thrombocytopenia and general treatment approaches. This page gathers peer-reviewed, open-access research relevant to immune thrombocytopenia and platelet disorders.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2015
2024
How this research is being cited
The 3 articles above have been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Dina Ashraf Abdelhady et al. · 2025 · European Journal of Medical Research
-
2025 · European journal of medical research
A sample of recent works citing this journal's research on Idiopathic Thrombocytopenic Purpura, linking to each citing work.